Patients who have HPV-positive HNSCC experience better outcomes than those with HPV-negative tumours and HPV-positive cases show lower rates of p53 tumor suppressor gene mutations.70, 71, 72. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.